71 related articles for article (PubMed ID: 2473356)
1. The vasodilating effect of atrial natriuretic peptide in normotensive and hypertensive humans.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S75-9. PubMed ID: 2473356
[TBL] [Abstract][Full Text] [Related]
2. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Bühler FR
J Hypertens Suppl; 1987 Dec; 5(5):S55-8. PubMed ID: 2965230
[TBL] [Abstract][Full Text] [Related]
3. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
Müller FB; Erne P; Raine AE; Bolli P; Linder L; Resink TJ; Cottier C; Bühler FR
J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
[TBL] [Abstract][Full Text] [Related]
4. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
6. [Does atrial antipressor natriuretic peptide play a pathophysiological role?].
Bühler FR
Schweiz Med Wochenschr; 1987 Dec; 117(49):1930-7. PubMed ID: 2962281
[TBL] [Abstract][Full Text] [Related]
7. [Role of atrial natriuretic peptide in the renal response to acute volume expansion in the normal and essential hypertensive patient].
Mimran A; Nussberger J; Ribstein J; Waeber B; Brunner HR
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():101-4. PubMed ID: 2973295
[TBL] [Abstract][Full Text] [Related]
8. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
[TBL] [Abstract][Full Text] [Related]
10. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
Valentin JP; Ribstein J; Nafrialdi N; Mimran A
Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
[TBL] [Abstract][Full Text] [Related]
11. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
12. Enhanced secretion and impaired natriuretic action of atrial natriuretic peptide in response to hypertonic saline infusion in patients with essential hypertension.
Akaike M; Nishiuchi T; Matsumoto N; Kawai H; Saito S
J Hum Hypertens; 1994 Jan; 8(1):15-8. PubMed ID: 8151600
[TBL] [Abstract][Full Text] [Related]
13. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
14. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
[TBL] [Abstract][Full Text] [Related]
15. The vasodilator potency of atrial natriuretic peptide in man.
Bolli P; Müller FB; Linder L; Raine AE; Resink TJ; Erne P; Kiowski W; Ritz R; Bühler FR
Circulation; 1987 Jan; 75(1):221-8. PubMed ID: 2947742
[TBL] [Abstract][Full Text] [Related]
16. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
Stimpel M; Kaufmann W; Wambach G
Z Kardiol; 1988; 77 Suppl 2():92-8. PubMed ID: 2970180
[TBL] [Abstract][Full Text] [Related]
17. Impaired vasodilator responses to atrial natriuretic peptide in essential hypertension.
Bulut D; Potthast R; Hanefeld C; Schulz T; Kuhn M; Mügge A
Eur J Clin Invest; 2003 Jul; 33(7):567-73. PubMed ID: 12814393
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular, renal, and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.
Edwards BS; Schwab TR; Zimmerman RS; Heublein DM; Jiang NS; Burnett JC
Circ Res; 1986 Dec; 59(6):663-7. PubMed ID: 2949886
[TBL] [Abstract][Full Text] [Related]
19. Effects of atrial natriuretic peptide on left ventricular function in hypertension.
Semigran MJ; Aroney CN; Herrmann HC; Dec GW; Boucher CA; Fifer MA
Hypertension; 1994 Sep; 24(3):271-9. PubMed ID: 8082932
[TBL] [Abstract][Full Text] [Related]
20. Arterial and venous effects of atrial natriuretic peptide in the human forearm.
Doorenbos CJ; Blauw GJ; van Brummelen P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):333-40. PubMed ID: 1829369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
